Aldeyra Therapeutics
ALDX
#10236
Rank
A$76.59 M
Marketcap
A$1.27
Share price
16.39%
Change (1 day)
-83.48%
Change (1 year)

Earnings for Aldeyra Therapeutics (ALDX)

Earnings in 2026 (TTM): -A$32.05 Million

According to Aldeyra Therapeutics 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$48.26 Million, an increase over its 2024 earnings that were of -A$81.48 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aldeyra Therapeutics from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$32.05 Million-33.6%
2025 -A$48.26 Million-40.77%
2024 -A$81.48 Million52.03%
2023 -A$53.59 Million-41.21%
2022 -A$91.15 Million7.67%
2021 -A$84.66 Million55.1%
2020 -A$54.59 Million-41.29%
2019 -A$92.97 Million58.81%
2018 -A$58.54 Million74.32%
2017 -A$33.59 Million19.56%
2016 -A$28.09 Million55.21%
2015 -A$18.1 Million142.32%
2014 -A$7.47 Million-137.39%
2013 A$19.97 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regeneron Pharmaceuticals
REGN
A$8.59 B-26,387.74%๐Ÿ‡บ๐Ÿ‡ธ USA